Active Pharmaceutical Ingredients

Explore our comprehensive portfolio of high-quality APIs, available for global markets with full regulatory support.

Abiraterone
Acalabrutinib
Allantoin
Allopurinol
Ambroxol
Atorvastatin Calcium Trihydrate (Crystalline)
Baclofen
Bisacodyl
Benfotiamine
Bortezomib
Brimonidine Tartrate
Butamirate Citrate
Cabazitaxel
Carbamide Peroxide
Cetylpyridinium Hcl
Citalopram
Clopidogrel Hcl
Colistimethate Sodium
Crizotinib
Cromolyn Sodium
Cyclopentolate Hcl
Cyclophosphamide
Dapagliflozin Propanediol Monohydrate
Dasatinib Anhydrous/Monohydrate
Deferiprone
Dibucaine/Cinhocaine Hcl
Disulfiram
Docetaxel Anhydrous/Trihydrate
Dorzolamide Hydrochloride
Eltrombopag Olamine
Empagliflozin
Eperisone Hcl
Eplerenone
Escitalopram Oxalate
Etamsylate
Etoposide
Febuxostat
Ferric Carboxymaltose
Fexofenadine
Fluconazole
Fosaprepitant
Gemcitabine Hydrochloride
Hydrochlorothiazide
Hydroquinone
Hydroxyurea ( Hydroxycarbamide )
Hydrous Benzoyl Peroxide
Ibrutinib
Imatinib
Irinotecan
Lansoprazole
Lapatinib Ditosylate Monohydrate
Latanoprost
Levetiracetam
Levofloxacin Hemihydrate
Magnesium Valproate
Memantine Hcl
Mesalamine
Miconazole Nitrate
Minoxidil
Mirtazapine
Nifedipine
Nifuroxazide
Nitrofurantoin Monohydrate / Anhydrous / Macro-crystal
Nitroglycerin / Glyceryl Trinitrate
Nebivolol Hcl
Ofloxacin
Olaparib
Oxetacaine
Paclitaxel
Palbociclib
Phenazone
Phenibut Hydrochloride
Phenobarbital / Phenobarbital Base
Pirfenidone
Policresulen
Propranolol HCl
Pyridoxal-5-phosphate (P-5-P)
Quetiapine Fumarate
Rifampicin
Rifaximin
Rosuvastatin Calcium
Sitagliptin Phosphate Monohydrate / Hydrochloride
Silver Sulfadiazine
Temozolomide
Thalidomide
Ticagrelor
Tigecycline Hydrochloride
Timolol Maleate
Tizanidine Hcl
Tolperisone Hcl
Torsemide
Tranexamic Acid
Trimetazidine Hcl
Tropicamide
UDCA
Valgancyclovir Hydrochloride
Zoledronic Acid

Important Notice

Vedura Pharmachem LLP does not offer for sale the Products protected by valid patents in countries, where the sale of such products constitutes a patent infringement. Only research & development quantities of such products are offered for the purpose of regulatory submissions in India and/or other jurisdiction, wherever such regulatory exemptions exist, according to Section 107A of the Indian Patent Act and the corresponding provision of the Patent Act of the respective jurisdiction. The final responsibility, with respect to third party patent rights in a specific country, lies exclusively with the buyer.